Author

A. Idbaih

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

T. Daubon· 2 shared A. Bikfalvi· 1 shared A. Biswas· 1 shared A. C. O'Farrell· 1 shared A. Eichmann· 1 shared A. Kremer· 1 shared A. Rezk· 1 shared A. T. Byrne· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

T. Daubon

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Identification of inter- and intra-tumoral molecular phenotypes steering temozolomide resistance in patient-derived glioblastoma cells.

F. Fabro, T. V. Kers, K. J. Feller, C. Beerens, I. Ntafoulis, A. Idbaih, M. Verrault, K. Connor, A. Biswas, M. Salvucci, J. H. M. Prehn, A. T. Byrne, A. C. O'Farrell, D. Lambrechts, G. Dilcan, , S. Leenstra

This study identifies two molecular phenotypes, ADA and N-ADA, associated with temozolomide resistance in glioblastoma cells through bulk and single-cell RNA sequencing.

bioRxiv · Aug 11, 2023Cancer Biology

Human glioblastoma cell motility depends on the activity of the cysteine metabolism enzyme 3-Mercaptopyruvate sulfurtransferase

M. S. Saurty-Seerunghen, T. Daubon, L. Bellenger, V. Delaunay, G. Castro, J. Guyon, A. Rezk, S. Fabrega, A. Idbaih, F. Almairac, F. Burel-Vandenbos, L. Turchi, T. Virolle, J.-M. Peyrin, C. Antoniewski, , M.-P. Junier

The paper identifies MPST as a key driver of glioblastoma cell motility through oxidative stress regulation, validated using patient-derived models and in vivo experiments.

bioRxiv · Jan 21, 2022Cancer Biology

SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia

L. H. Geraldo, Y. Xu, L. Jacob, L. Pibouin-Fragner, R. Rao, N. Maissa, M. Verreault, N. Lemaire, C. Knosp, C. Lesaffre, T. Daubon, J. Dejaegher, L. Solie, J. Rudewicz, T. Viel, , T. Mathivet

This study shows that SLIT2-ROBO signaling in tumor-associated microglia/macrophages promotes glioblastoma immunosuppression and vascular dysmorphia, and its inhibition reduces tumor growth and enhances therapy.

bioRxiv · Apr 12, 2021Cancer Biology